Short answer
Lucid Diagnostics Inc. (LUCD) filed its Q3 2025 10-Q quarterly report on Nov 12, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $1M (up 3.3% year over year) with net income of −$10M.
Q3 2025 key financials · XBRL
- Revenue
- $1M
- +3.3% YoY · +4.1% QoQ
- Net income
- −$10M
- +16.0% YoY · −134.2% QoQ
- Operating margin
- -970.9%
- EPS (diluted)
- −$0.07
- +72.0% YoY
Source: XBRL data from the Lucid Diagnostics Inc. (LUCD) Q3 2025 10-Q on SEC EDGAR. USD.
Lucid Diagnostics Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $1.2M, relatively level versus September 2024
- Quarterly cost of revenue approximately $1.7M, relatively level year over year
- Sales and marketing expense $4.3M vs $4.1M; general and administrative expense $5.6M vs $5.4M
- Research and development expense $1.3M vs $1.7M, primarily from lower clinical-trial activity
- September offering net proceeds approximately $27.0M; proceeds designated for working capital and general corporate purposes
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Lucid Diagnostics Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.